Skip to content

Clinical trials

Phase 3 Kidney Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Phase: Phase 3 Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20152
20191
20201
20221
20233
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Bayer2
AstraZeneca1
Dimerix Bioscience Pty Ltd1
Eli Lilly and Company1
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1
Human Genome Sciences Inc., a GSK Company1
Panion & BF Biotech Inc.1
Sun Yat-sen University1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases13
Renal Insufficiency, Chronic6
Glomerulonephritis4
Glomerulonephritis, IGA3
Urologic Diseases3
Diabetes Mellitus, Type 22
Diabetic Nephropathies2
Lupus Nephritis2
Renal Insufficiency2
Autoimmune Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.